Compare TNET & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TNET | QDEL |
|---|---|---|
| Founded | 1988 | 1979 |
| Country | United States | United States |
| Employees | 2700 | N/A |
| Industry | Business Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.0B |
| IPO Year | 2000 | 2022 |
| Metric | TNET | QDEL |
|---|---|---|
| Price | $38.89 | $12.69 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 4 |
| Target Price | ★ $65.80 | $28.25 |
| AVG Volume (30 Days) | 385.1K | ★ 2.0M |
| Earning Date | 04-24-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.87% | N/A |
| EPS Growth | N/A | ★ 45.35 |
| EPS | ★ 3.20 | N/A |
| Revenue | ★ $5,010,000,000.00 | $2,730,200,000.00 |
| Revenue This Year | N/A | $3.51 |
| Revenue Next Year | $3.30 | $3.86 |
| P/E Ratio | $11.98 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $33.67 | $13.70 |
| 52 Week High | $88.56 | $37.24 |
| Indicator | TNET | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 54.21 | 35.13 |
| Support Level | $34.55 | N/A |
| Resistance Level | $39.22 | $30.65 |
| Average True Range (ATR) | 1.72 | 1.31 |
| MACD | 0.51 | 0.22 |
| Stochastic Oscillator | 86.64 | 15.21 |
Trinet Group Inc provides human resources solutions for small and medium-sized businesses through technology-enabled services. Its offerings include human capital expertise, employee benefits such as health insurance and retirement plans, payroll and payroll tax administration, risk mitigation, and compliance consulting. The company provides its services through professional employer organization (PEO) services delivered via a co-employment model, as well as administrative services organization (ASO) offerings. The majority of the company's revenue is derived from the insurance-related billings and administrative fees collected from PEO clients.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.